DK1928431T3 - Farmaceutisk "controlled release"-præparat der indeholder carvedilol - Google Patents

Farmaceutisk "controlled release"-præparat der indeholder carvedilol

Info

Publication number
DK1928431T3
DK1928431T3 DK06779688T DK06779688T DK1928431T3 DK 1928431 T3 DK1928431 T3 DK 1928431T3 DK 06779688 T DK06779688 T DK 06779688T DK 06779688 T DK06779688 T DK 06779688T DK 1928431 T3 DK1928431 T3 DK 1928431T3
Authority
DK
Denmark
Prior art keywords
controlled release
pharmaceutical
composition containing
containing carvedilol
carvedilol
Prior art date
Application number
DK06779688T
Other languages
Danish (da)
English (en)
Inventor
Pal Fekete
Zoltan Budavari
Zsolt Zsigmond
Agnes Bozso
Huszar Magdolna Leventiszne
Zoltanne Palfi
Palne Szentgroti
Karacs Erika Davidne
Kuncze Aniko Turoczine
Krisztina Abraham
Original Assignee
Egis Gyogyszergyar Nyilvanosan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Nyilvanosan filed Critical Egis Gyogyszergyar Nyilvanosan
Application granted granted Critical
Publication of DK1928431T3 publication Critical patent/DK1928431T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK06779688T 2005-08-26 2006-08-23 Farmaceutisk "controlled release"-præparat der indeholder carvedilol DK1928431T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0500803A HU227490B1 (en) 2005-08-26 2005-08-26 Sustained release pharmaceutical preparation containing carvedilol
PCT/HU2006/000068 WO2007023325A2 (en) 2005-08-26 2006-08-23 Controlled release pharmaceutical composition containing carvedilol

Publications (1)

Publication Number Publication Date
DK1928431T3 true DK1928431T3 (da) 2009-04-20

Family

ID=89986232

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06779688T DK1928431T3 (da) 2005-08-26 2006-08-23 Farmaceutisk "controlled release"-præparat der indeholder carvedilol

Country Status (11)

Country Link
EP (1) EP1928431B8 (de)
AT (1) ATE418969T1 (de)
DE (1) DE602006004610D1 (de)
DK (1) DK1928431T3 (de)
EA (1) EA013058B1 (de)
ES (1) ES2321980T3 (de)
HU (1) HU227490B1 (de)
NO (1) NO20081481L (de)
PL (1) PL1928431T3 (de)
PT (1) PT1928431E (de)
WO (1) WO2007023325A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
JP2009503020A (ja) 2005-08-03 2009-01-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 肥満症の治療におけるフリバンセリンの使用
EP1945214A1 (de) 2005-10-29 2008-07-23 Boehringer Ingelheim International GmbH Benzimidazolon-derivate zur behandlung von prämenstruellen und anderen sexuellen störungen der frau
DE602007004615D1 (de) 2006-06-30 2010-03-18 Boehringer Ingelheim Pharma Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
JP5793828B2 (ja) 2006-08-14 2015-10-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング フリバンセリンの製剤及びその製造方法
CN101505736A (zh) 2006-08-25 2009-08-12 贝林格尔.英格海姆国际有限公司 控制释放系统及其制造方法
HU227881B1 (en) * 2007-02-23 2012-05-29 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Sustained release pharmaceutical preparation containing carvedilol
PE20091188A1 (es) 2007-09-12 2009-08-31 Boehringer Ingelheim Int Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen
US9700520B2 (en) 2007-09-21 2017-07-11 Evonik Roehm Gmbh PH-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol
WO2009047800A2 (en) * 2007-10-09 2009-04-16 Lupin Limited Oral controlled release composition of carvedilol
US8133506B2 (en) * 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
CN103099793B (zh) * 2013-02-06 2015-07-15 中国人民解放军第二军医大学 片剂及其制备方法
JP7336187B2 (ja) * 2017-11-30 2023-08-31 日本ケミファ株式会社 多層構造を有する粒子状医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004518734A (ja) * 2000-10-24 2004-06-24 スミスクライン・ビーチャム・コーポレイション カルベジロールの新規処方
DE10209982A1 (de) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe
AU2003288608A1 (en) * 2002-12-20 2004-07-14 Ranbaxy Laboratories Limited Controlled release, multiple unit drug delivery systems

Also Published As

Publication number Publication date
EA013058B1 (ru) 2010-02-26
HU227490B1 (en) 2011-07-28
EP1928431A2 (de) 2008-06-11
NO20081481L (no) 2008-05-19
HUP0500803A3 (en) 2008-03-28
DE602006004610D1 (de) 2009-02-12
HUP0500803A2 (en) 2007-05-29
WO2007023325A2 (en) 2007-03-01
ATE418969T1 (de) 2009-01-15
PL1928431T3 (pl) 2009-07-31
ES2321980T3 (es) 2009-06-15
EP1928431B1 (de) 2008-12-31
WO2007023325A3 (en) 2007-06-28
EP1928431B8 (de) 2009-04-08
HU0500803D0 (en) 2005-11-28
EA200800666A1 (ru) 2008-06-30
PT1928431E (pt) 2009-03-25

Similar Documents

Publication Publication Date Title
DK1928431T3 (da) Farmaceutisk "controlled release"-præparat der indeholder carvedilol
WO2009113703A3 (en) Orally-disintegrating solid preparation
WO2007041367A3 (en) Oral composition containing a salivation inducing agent
IL181117A (en) Sustained drug release composition demonstrating an ascending zero order release pattern and methods of manufacturing such a composition
ATE538185T1 (de) Laserempfindliche beschichtungszusammensetzung
RS54929B1 (sr) Formulacija i metod obložene tablete
WO2007149801A3 (en) Enteric coated particles containing an active ingredient
NO20092632L (no) Jern (III)-basert fosfatadsorbent, fremgangsmåte for fremstilling derav, anvendelser derav og farmasøytisk preparat inneholdende nevnte adsorbent.
RS52891B (en) GASTRORE-RESISTANT PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMINE
FI10176U1 (fi) Pohjamateriaali
WO2009140018A3 (en) Microencapsulated delivery system
LT1840145T (lt) Acetileno karbamido dariniai - polikarbamido polimerai ir mikrokapsulės ir kompozicijos jų kontroliuojamam atpalaidavimui
WO2006099514A3 (en) Drug delivery compositions and related methods
RS53056B (en) PHARMACEUTICAL PREPARATION CONTAINING (1S) -1,5-ANHYDRO-1- [5- (4-ETHOXYBENZYL) -2-METHOXY-4-METHYLPHENYL] -1-THI-D-GLUCITOL AND METFORMIN AND ITS USE IN THE TREATMENT OF DIABETES
CL2007003265A1 (es) Compuestos derivados de 1h-piran[2,3-d]pirimidin-2,4,7-triona; y composicion farmaceutica, util para el tratamiento de sindrome metabolico, dislipidemia y enfermedades cardiovasculares entre otras.
EP2368546A4 (de) Pharmazeutische zusammensetzung für die gesteuerte freisetzung von methylphenidat
DE502007002695D1 (de) Retardtabletten mit Hydromorphon
MX2012008908A (es) Pelicula que se puede rotular con laser resistente al calor.
BRPI0600546A (pt) método para preparação de um substrato revestido
TW200611860A (en) Substrate for flexible display
ATE521339T1 (de) Pharmazeutische zusammensetzung aus venlafaxin- hydrochlorid mit kontrollierter freisetzung und herstellungsverfahren dafür
WO2009057138A3 (en) Controlled release pharmaceutical compositions of tolterodine
WO2006029772A3 (de) Thixotrope beschichtungsmassen
WO2005099372A3 (en) Release agent-free, multiple-use, polymer-based composite materials employed for concrete pouring forms and methods of making and using the same
BR0313220A (pt) Pelìcula de revestimento para comprimidos e cápsulas